What the 2025 research review found on Epithalon and telomeres The 2025 overview in the International Journal of Molecular Sciences examined the full body of Epithalon research and concluded that the peptide can activate telomerase and extend telomere length in human cell cultures, with effects observed beyond the standard Hayflick limit while preserving cellular morphology and function
Johnson Principal, Strategy and Transaction, EY-Parthenon, Ernst & Young LLP | EY - US Ranu Carroll, EY-Parthenon Americas Life Sciences Sector Leader Liam Li Senior Director, Strategy and Transaction, EY-Parthenon, Ernst & Young LLP Moderator: Will Auchincloss EY-Parthenon Americas Retail Sector Leader | EY - US
The trial also showed that around 65 per cent of patients taking the highest dose reached a body mass index (BMI) below 30, moving them out of the obesity category
The doctor will then closely monitor the patients blood work to ensure the body is safely clearing the medication before considering any dose increases
Hypoglycemia represents a serious acute risk, as IGF-1 DES possesses potent insulin-like metabolic effects including enhanced glucose uptake into muscle and adipose tissue, increased glycogen synthesis, and suppression of hepatic glucose output
.png)
